DiaMedica Therapeutics (DMAC) Other Working Capital Changes: 2018-2019

Historic Other Working Capital Changes for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to -$42,000.

  • DiaMedica Therapeutics' Other Working Capital Changes fell 120.10% to -$42,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$322,000, marking a year-over-year decrease of 204.55%. This contributed to the annual value of -$184,000 for FY2024, which is 215.00% down from last year.
  • Per DiaMedica Therapeutics' latest filing, its Other Working Capital Changes stood at -$42,000 for Q4 2019, which was up 61.47% from -$109,000 recorded in Q3 2019.
  • DiaMedica Therapeutics' 5-year Other Working Capital Changes high stood at $209,000 for Q4 2018, and its period low was -$109,000 during Q3 2019.
  • Over the past 2 years, DiaMedica Therapeutics' median Other Working Capital Changes value was -$27,500 (recorded in 2018), while the average stood at -$1,750.
  • Data for DiaMedica Therapeutics' Other Working Capital Changes shows a maximum YoY plummeted of 453.85% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows DiaMedica Therapeutics' Other Working Capital Changes stood at $209,000 in 2018, then tumbled by 120.10% to -$42,000 in 2019.
  • Its last three reported values are -$42,000 in Q4 2019, -$109,000 for Q3 2019, and -$99,000 during Q2 2019.